Table 2.
Clinical related variable | Cases (N = 119) | Controls (N = 238) | P value | |
---|---|---|---|---|
n (%) | n (%) | COR | ||
WHO clinical stage | ||||
Stages I and II | 43 (36.1) | 129 (54.2) | 1.00 | |
Stages III and IV | 76 (63.9) | 109 (45.8) | 2.09 (1.33, 3.28) | 0.001* |
Haemoglobin level | ||||
<10 | 13 (10.9) | 13 (5.5) | 2.96 (1.28, 6.80) | 0.01* |
10–12.49 | 56 (47.1) | 77 (32.4) | 2.08 (0.59, 3.19) | 0.45 |
≥12.5 | 50 (42) | 148 (62.2) | 1.00 | |
CD4 count | ||||
<200 | 33 (27.7) | 41 (17.2) | 2.35 (1.23, 4.48) | 0.009* |
200–499 | 61 (51.3) | 124 (52.1) | 1.48 (0.94, 2.84) | 0.08 |
≥500 | 25 (21) | 73 (30.7) | 1.00 | |
BMI | ||||
<18.5 | 67 (56.3) | 60 (25.2) | 3.80 (2.39, 6.08) | <0.001* |
≥18.5 | 52 (43.7) | 178 (74.8) | 1.00 |
*Statistically significant.